Delivery Order SPE2DB22D9244-SPE2DB25FZQ85

Award Date 10/21/24
Potential Completion Date 11/12/24
Potential Value $2.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,009.65 firm fixed-price delivery order is for the supply of the Kyleena 19.5 mg intrauterine system contraceptive device. This award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program,...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,407.72 firm fixed-price delivery order, which is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999, was awarded on May 9, 2024 and has an ultimate completion date of May 29, 2024. The contract does not have a set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,611.58 firm fixed-price delivery order is for the provision of the medical device Kyleena, a 19.5 mg intrauterine system, to support the recurring pharmaceutical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract...
This federal contract award is to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,814.82, was awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain division. It is a delivery order contract for the supply of pharmaceutical products, including the Kyleena 19.5 mg intrauterine contraceptive system. The contract has a firm fixed-price pricing type and a completion date of June...
This federal contract award, with ID SPE2DB24D9238|SPE2DB25FDQEW, is a $2,347.24 firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of the medication Kyleena, a 19.5 mg intrauterine system, with a completion date of November 19, 2024. DMS Pharmaceutical Group Inc. holds a $499,999,999 single-award Indefinite Delivery...
This federal contract award, valued at $7,436.28, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of the medical device Kyleena, a 19.5 mg intrauterine system, to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $14,002.56, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order to supply the KYLEENA 19.5 MG SYSTEMS product. DMS Pharmaceutical Group Inc. holds a large indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs through December 31, 2025. This single-award vehicle, under the...
This federal contract award is for the delivery of the pharmaceutical product Kyleena, a 19.5 mg intrauterine system, to the Defense Logistics Agency (DLA). The contract, valued at $1,805.79, was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,873.50 firm fixed-price delivery order contract is for the provision of Kyleena 19.5 mg systems, a type of intrauterine contraceptive device. The contract is not associated with any set-aside designation, allowing DMS Pharmaceutical Group to leverage its woman-owned small business status to...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a $2,407.68 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, which has a performance period through May 17, 2024, is to provide the DLA's Medical Supply Chain division with a Kyleena 19.5 mg intrauterine system. This delivery order is part of a larger $499,999,999 indefinite delivery contract (SPE2DB) held by DMS...
  • SPE2DB22D9244
    Indefinite Delivery Contract
  • SPE2DB22D9244-SPE2DB25FZQ85
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,919.35 firm fixed-price delivery order is for the supply of the medical device Kyleena, a 19.5 mg intrauterine system. The contract has an ultimate completion date of November 12, 2024 and is not associated with any set-aside designations.

DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide, positioning DMS Pharmaceutical Group as a crucial supplier in the federal pharmaceutical supply chain.

Generated 4/1/25, 8:43 AM